RTsafe is a #medical#technology company that has developed a unique approach to quality assurance to enhance the safety & accuracy of #radiotherapy for #cancer
🚀 We have just wrapped up the @ISRSy Congress 2026!
We are more than happy to meet with all of you in Sydney!
Congratulations and many thanks to the ISRS Society for the trust and support!
See you in Toronto!
#ISRS2026#auditservices
Great to be here at the @ISRSy Congress 2026 and connect with so many of you, partners, colleagues, and new collaborators from across the globe!
Thanks for the great conversations, your feedback and insights mean a lot to us. See you tomorrow for the final day of #ISRS2026!
🎯 Don’t forget to register for our upcoming webinar on June 17, at 16:00 EEST lead by lead by Florin Costache, Medical Physicist Expert, titled ’End-to-End dosimetry audit for SRS/SBRT: Optional or mandatory at the beginning of the journey? 👉https://t.co/KE5jwnaNNg
The International Stereotactic Radiosurgery Society (ISRS) corporate news Spring 2026 has been published.
Check out RTsafe’s article titled – Advancing End-to-End quality assurance in modern radiotherapy: Clinical research projects with RTsafe👉https://t.co/YBdozh8zPP
We are delighted to announce our webinar on June 17, at 16:00 EEST lead by Costache Florin, Medical Physicist Expert, titled ’End-to-End dosimetry audit for SRS/SBRT: Optional or mandatory at the beginning of the journey?
Register now at the link below👉https://t.co/jbEW9qyGiS
Proud to share that Dr Penny Kechagioglou has joined the RTsafe Board of Directors.
Her appointment comes at an exciting and important time for RTsafe.
Welcome to the Board, Penny! We are truly happy to have you with us. Read more- https://t.co/Db490Je1jB
We are thrilled to announce that @RTsafe is participating in the @ISRSy Congress 2026 in Sydney!
Learn more about RTsafe’s presence in ISRS Congress 2026 here 👉https://t.co/WRzNKfb2FL
We’re proud to announce @RTsafeGulf’s first commercial agreement in the UAE with American Hospital Dubai Science Park.
Read the full press release here 👉https://t.co/nFBIjuQ8Va
At @RTsafe , we collaborate with Nicola Franza from DOSIMETRICA, to deliver advanced SRS and SBRT Audit Services to radiotherapy centers across Italy, helping ensure the highest levels of precision, safety, and confidence in treatment delivery.
Learn more- https://t.co/WqwXKq7UC6
We are pleased to share the results of a multicenter study on intracranial stereotactic radiotherapy (SRT) planning quality, involving 24 radiotherapy centers across Switzerland.
Read the study here👉https://t.co/tAhcLmyQCm
#medicalphysics#qualityassurance#brainmetastases
You no longer need to purchase phantoms, lease them from RTsafe instead!
We are pleased to offer you RTsafe’s leasing model that promises to transform your radiation therapy services: the Remote Dosimetry Services Bundle, featuring our SRS and SBRT phantoms.
The @EFOMP_org newsletter- Spring 2026 has been published.
Check out RTsafe’s article (p 38) titled - Advancing End-to-End quality assurance in modern radiotherapy: Clinical Research Projects with RTsafe👉https://t.co/rLSP7c5Eqr
RTsafeGulf Becomes the First Company globally Licensed by Federal Authority for Nuclear Regulation to Provide Radiotherapy Medical Physics Services in the United Arab Emirates.
Learn more here 📷 https://t.co/bvp27GVw1d
#radiationsafetyservices#medicalphysicsservices
#PatientSafetyAwareness Week is an annual recognition event intended to encourage everyone to learn more about health care hashtag#safety.
All of us in RTsafe are fully committed to Patient Safety.
Learn more about our PseudoPatient👉 https://t.co/SmUDGhUlt6
#patientsafety
Have you explored @RTsafe Audit Services yet?
At RTsafe, we’re committed to fostering a culture of excellence in radiation therapy. Our Audit Services are specifically designed to enhance the accuracy and safety of SRS and SBRT applications.
Read more👉https://t.co/WqwXKq7UC6
We are proud to announce that @RTsafe and the @ISRSy have extended their strategic cooperation for another 3 years.
We thank ISRS for their continued confidence and look forward to the years ahead!
On February 4, 2026, our core innovation, PseudoPatient®, received official Medical Device Marketing Authorization (MDMA-2-2026-0352) from the Saudi Food & Drug Authority (SFDA).
Press here to read more👉https://t.co/uOGOBwW1SW
#PseudoPatient#QualityAssurance